Wall Street Reacts To Celgene's Reported Interest In Juno By: Benzinga via Benzinga January 17, 2018 at 15:39 PM EST Shares of Juno Therapeutics Inc (NASDAQ: JUNO) soared higher by 50 percent Wednesday after reports surfaced that the company is being ... Read More >> Related Stocks: Bluebird Bio Celgene Corp